Revvity
RVTY · NYSE
Bulios Fair Price
$111.52
10.4% downside
Current Price
$124.4
According to Bulios Fair Price, RVTY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. With a global network and localized agility, the company serves a diverse range of organizations from pharmaceutical and biotech to clinical labs, academia, and governments. It is headquartered in Waltham, MA.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Prahlad R. Singh
Employees
11,000
Headquarters
Waltham
Upcoming events
Ex-Dividend
Ex-dividend date
Earnings
Upcoming earnings report
Dividend Payment
Payment date